Armenia

v. 15 – Q3 2020

Market Executive Summary Reports in February 2016 that lawmakers are considering a bill “On Drugs” to provide for strict control over the entire supply chain – from the production of medicines to their sales. The amendments are designed to bring the Armenian pharmaceutical products in line with international standards. The bill also aims to introduce price regulation mechanisms.

  • New bill “On Drugs” is based on norms of international agreements
  • Few requirement details issued
  • Under the umbrella of Eurasian Economic Union
  • Following EAEU rule for medicines registration and assessments (from 2018)
Key Dates June 13, 2016: Bill “On Drugs” NoZP is published, amendments to bill:

  • March 28, 2018, NoZP-171: Inspection organ, enforced by the Government of Armenia will perform the state control of the drug’s circulation
  • December 12, 2019, NoZP-268: Obligation of license for wholesalers and certificate of activity for the proper distribution of medicine (within 4 years after the license obtention)
  • From February 7, 2020 – NoZP-42

<-- Return to Countries